These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2036615)

  • 41. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility.
    Majoor-Krakauer D; Ottman R; Johnson WG; Rowland LP
    Neurology; 1994 Oct; 44(10):1872-7. PubMed ID: 7936240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India.
    Nalini A; Thennarasu K; Gourie-Devi M; Shenoy S; Kulshreshtha D
    J Neurol Sci; 2008 Sep; 272(1-2):60-70. PubMed ID: 18550082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival analysis of geospatial factors in the Irish ALS cohort.
    Rooney J; Heverin M; Vajda A; Burke T; Galvin M; Tobin K; Elamin M; Staines A; Hardiman O
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):555-560. PubMed ID: 27145090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N19S, a new SOD1 mutation in sporadic amyotrophic lateral sclerosis: no evidence for disease causation.
    Mayeux V; Corcia P; Besson G; Jafari-Schluep HF; Briolotti V; Camu W
    Ann Neurol; 2003 Jun; 53(6):815-8. PubMed ID: 12783432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical characteristics of elderly Japanese patients with amyotrophic lateral sclerosis; with special reference to the development of respiratory failure].
    Terao S; Miura N; Osano Y; Adachi K; Sobue G
    Rinsho Shinkeigaku; 2006 Jun; 46(6):381-9. PubMed ID: 16986698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience.
    Gordon PH; Salachas F; Lacomblez L; Le Forestier N; Pradat PF; Bruneteau G; Elbaz A; Meininger V
    Neurodegener Dis; 2013; 12(2):81-90. PubMed ID: 22922503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An observational study of cognitive impairment in amyotrophic lateral sclerosis.
    Rippon GA; Scarmeas N; Gordon PH; Murphy PL; Albert SM; Mitsumoto H; Marder K; Rowland LP; Stern Y
    Arch Neurol; 2006 Mar; 63(3):345-52. PubMed ID: 16533961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic epidemiology of amyotrophic lateral sclerosis.
    Majoor-Krakauer D; Willems PJ; Hofman A
    Clin Genet; 2003 Feb; 63(2):83-101. PubMed ID: 12630951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of amyotrophic lateral sclerosis and frontotemporal dementia.
    Lomen-Hoerth C
    Dement Geriatr Cogn Disord; 2004; 17(4):337-41. PubMed ID: 15178949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathophysiological insights into ALS with C9ORF72 expansions.
    Williams KL; Fifita JA; Vucic S; Durnall JC; Kiernan MC; Blair IP; Nicholson GA
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):931-5. PubMed ID: 23463871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ALSFRSr predicts survival time in an ALS clinic population.
    Kaufmann P; Levy G; Thompson JL; Delbene ML; Battista V; Gordon PH; Rowland LP; Levin B; Mitsumoto H
    Neurology; 2005 Jan; 64(1):38-43. PubMed ID: 15642901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998.
    Sorenson EJ; Stalker AP; Kurland LT; Windebank AJ
    Neurology; 2002 Jul; 59(2):280-2. PubMed ID: 12136072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amyotrophic lateral sclerosis: early predictors of prolonged survival.
    Czaplinski A; Yen AA; Appel SH
    J Neurol; 2006 Nov; 253(11):1428-36. PubMed ID: 16773270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis.
    Pinto S; Pinto A; de Carvalho M
    Clin Neurophysiol; 2012 Dec; 123(12):2454-9. PubMed ID: 22762911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amyotrophic lateral sclerosis: a population study.
    Kahana E; Alter M; Feldman S
    J Neurol; 1976 Jun; 212(3):205-13. PubMed ID: 58973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis.
    Gargiulo-Monachelli GM; Janota F; Bettini M; Shoesmith CL; Strong MJ; Sica RE
    Eur J Neurol; 2012 Jun; 19(6):834-41. PubMed ID: 22248150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotypic and genotypic heterogeneity of dominantly inherited amyotrophic lateral sclerosis.
    Chio A; Brignolio F; Meineri P; Schiffer D
    Acta Neurol Scand; 1987 Apr; 75(4):277-82. PubMed ID: 3591277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.
    Haverkamp LJ; Appel V; Appel SH
    Brain; 1995 Jun; 118 ( Pt 3)():707-19. PubMed ID: 7600088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis.
    Tortelli R; Arcuti S; Copetti M; Barone R; Zecca C; Capozzo R; Barulli MR; Simone IL; Logroscino G
    Acta Neurol Scand; 2018 Jul; 138(1):55-61. PubMed ID: 29527672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Survival prediction and related risk factors of amyotrophic lateral sclerosis:analysis of 65 cases].
    Qiao L; Zhang J; Fan DS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):742-5. PubMed ID: 18683681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.